Large-scale testing (Phase 3)Study completedNCT02480712
What this trial is testing
Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection
Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 107